. There was a strong correlation between serum SA levels and proteinuria (p=0.001, r=0.5). There was a significant association between SIAE gene variation and proteinuria (393±238 vs 107±185 mg\L, p= 0.021) , diastolic blood pressure (102.7±21.9 vs 85.7±20.6 mmHg, p=0.01 
INTRODUCTION
Pre-eclampsia is defined as hypertension and proteinuria, which is commonly observed in nullipares after 20th gestational week (1) . It is one of the important causes of fetomaternal morbidity and mortality, which includes a broad spectrum varying from PE and minimal increases of blood pressures to severe organ dysfunctions (2) .
Although abnormal trophoblast invasion of the uterine blood vessels, vascular endothelial dysfunction, incompatibility with inflammatory and cardiovascular changes occurring during the pregnancy and various genetic predispositions are believed to account for the etiopathogenesis of PE, this has not been fully elucidated yet (3) .
It is known that preeclampsia is characterized by an excessive increase of maternal inflammatory response and the factors that trigger the inflammatory response (infections and rheumatoid diseases) increased the likelihood of PE occurrence (4, 5) . In the etiopathogenesis of the cardiovascular diseases (CVD), inflammatory cell activation is accounted for the occurrence of endothelial dysfunction, thrombotic and metabolic disorders. Increased risk for future CVD in the preeclamptic pregnant women and the fact that atherosclerosis and obesity are common risk factors for PE and CVD support the important role of inflammatory cell activation in the etiopathogenesis of PE (6, 7) .
Sialic acid (SA) is a general name given to acetylated derivatives of the neuraminic acid (8) . Main role of the SA is to ensure the interaction between the cells and the infectious agents by regulating the molecular relations as well as structural and protective effects in the cell membrane (9) . Increased serum level of total SA was documented in various inflammatory diseases (10) . There was a correlation between serum total SA level and acute phase proteins activated during the inflammation (11) . As a result, SA may be considered (12, 13) .
It is known that there is a strong familial predisposition to preeclampsia. Although many candidate genes have been shown as a risk factor for the recent years, the literature does not contain a study that eval›ated the correlation between SIAE gene variation and PE (14, 15) .
This study aimed to determine whether serum total SA level and sialic acid acetyl esterase (SIAE) gene variation could be used as a risk factor to priorly diagnose the preeclampsia and to determine its severity and to take precautions in the early prenatal period.
MATERIAL AND METHODS
We enrolled 57 preeclamptic pregnant women with a gestational age between 28 and 40 weeks and 50 healthy pregnant women without any medical problems, who were presented to the Department of Gynecological Preeclampsia was diagnosed based on the observation of a blood pressure ≥140/90 mmHg and urinary protein level ≥300 mg/L (at least +1, using dipstick) during 2 measurements performed with at least 6-hour intervals.
Severe PE criteria included blood pressure ≥160/110, proteinuria ≥5gr/24 hours or 3+/4+ on stick test, oliguria (≥500 ml/24 hours), impaired vision, cerebral disorder, convulsion, headache, epigastric pain, nausea, vomiting, elevation of serum creatinine level, thrombocytopenia (<100000), impairment of hepatic functions or peripheral smear, pulmonary edema and cyanosis, abnormal umbilical artery Doppler findings as well as intrauterine growth restriction or oligohydramniosis (16, 17) . Control group included the pregnant women without any medical problem, who had normal results of renal and hepatic function tests and blood pressure.
For both groups, sociodemographic, reproductive, medical and laboratory data and ultrasound findings of the fetus were recorded in the patient monitorization forms. Exclusion criteria included multiple pregnancies, fetal anomaly, maternal infection or maternal systemic disease.
Each patient gave a total of 7 ml peripheral blood, 5 ml being drawn in normal tube to evaluate serum total SA level and 2 ml being drawn to EDTA tube for the detection of the polymorphism located in SIAE promoter domain. Blood samples drawn for the determination of serum SA level were centrifuged at 1600 g/min for 15 minutes and the serum samples obtained were stored at -80°C until the time of use.
For the measurement of serum total SA level, Denny's colorimetric method was used (18) . This method is the modified version of Aminoff and Warren methods, which are thiobarbituric acid (TBA) colorimetric assays that are commonly used for the measurement of total SA level (19, 20) . For the analysis of SIAE gene variation, DNAs were isolated from the peripheral blood samples obtained from patient and control groups using the precipitation method at high salt concentrations and were stored at -20°C (21) . SIAE gene was studied using the primers regulated in the program of wrokxx banch designed for promoter domain (13) . The concerned domains were amplified using polymerase chain reaction (PCR) and thereafter, the amplifications of the samples were controlled using 2% agarose gel, the analysis of the differences of domains were conducted by performing Single stranded conformational polymorphism (SSCP) analysis using 7% nondenaturated page and the visualization was done using staining with silver (22) .
The results obtained from the study were evaluated within 95% confidence intervals and at a significance level of p<0.05 using SPSS 13.0 (Statistical Package for Social Sciences) software. Continuous variables were compared using Independent T Test or MannWhitney U test between two groups, whereas ANOVA test was used when the number of groups was above two. Categorical variables were compared using chisqaure test and Fisher's exact test between the groups. Risk coefficients were calculated using odss ratio and 95% confidence intervals were given. Correlation 
RESULTS
For 57 pregnant women of PE groups (20 mild preeclampsia and 37 severe preeclampsia) and 50 pregnant women of the control group, demographic and clinical findings were given in Table I . Serum levels of sialic acid were statistically significantly elevated in PE group (3.53±1.37 mmol/l) compared to control group (2.32±0.68 mmol\l) (p<0.00001) ( Table   II) . When the patient group was divided into two subgroups called mild and severe PE, serum levels of sialic acid was significantly elevated in both mild and severe PE groups (3.8±0.9, 3.3±1.5 mmol\l, respectively) compared to control group (2.3±0.7 mmol\l) (p<0.001, p<0.001), but no significant difference was found between mild and severe PE groups (p=0.22) ( Figure   1 ). Serum levels of SA showed a mild-moderate correlation with diastolic blood pressure and the levels of uric acid (p=0.0001, r=0.34; p=0.0001, r=0.37, respectively) and a strong correlation with proteinuria (p=0.001, r=0.5) (Table III) . To diagnose PE based on the serum level of SA, "Receiver-operating characteristic" (ROC) analysis was used. Area under the ROC curve between preeclampsia and sialic acid was evaluated to be 0.811 (CI %95; 0.731-0.892, p<0.001) (Figure 2 ). In the preeclampsia, when the level of sialic acid was considered as 2.31 mmol/l, the sensitivity was 80%, specificity was 50%, positive predictor value was 61%
and negative predictive value was 30%.
Preeclamptic pregnant women showed a significantly higher gene variation compared to those of control group and the likelihood of gene variation was 10.4 times more common in preeclamptic pregnant women compared to those of control group (Table II) . When PE group was divided into subgroups, SIAE gene variation rate was significantly higher in severe PE group (p:0.001; OR:
15.7, %95 CI; 1.8-130.8) and was higher with a borderline significance in the mild PE group (p:0.06 OR: 6.1 (%95 CI; 0.7-52.2).
A significant correlation was found between SIAE gene variation rate and proteinuria (393±238 vs.
107±185 mg\L, p= 0.021) and diastolic blood pressure (102.7±21.9 vs. 85.7±20.6 mmHg, p=0.01) (Table IV) .
DISCUSSION
Despite many actual studies, the etiopathogenesis of the preeclampsia has not been fully understood.
It is known that the inflammatory condition observed in the normal pregnancy modifies and increases with the activation of neutrophiles in PE (23, 24) . The studies that have been conducted for the last years suggested that the sialic acid that has been demonstrated to be correlated with acute phase reactants could play a role in the etiopathogenesis of the PE. However, in the literature, the studies that evaluated SA in the preeclamptic pregnant women were very limited.
In the literature, the only study that evaluated serum levels of SA in the preeclamptic pregnant women was the study conducted by von Versen-Hoeynck FM et al., which evaluated the levels of SA and CRP in five different groups, as non-pregnant women, healthy pregnant women, preeclamptic pregnant women, the pregnant women who showed SGA without preeclampsia and the pregnant women who showed temporary hypertension (25) . In this study, the levels of SA were found to be correlated with CRP and neopterine, but the level of neopterine was statistically significantly higher in the preeclamptic pregnant women, whereas this difference could not be demonstrated for the levels of SA and CRP. In our study, unlike the study conducted by von Versen- the level of SA was measured using diagnostic kit, but no detailed information was given about the measurement method, i.e., it was not stated whether total or free SA was measured. In our study, serum total SA measurement was performed using Denny's colorimetric method. This study has been the first study present in the English literature that revealed the importance of serum level of total SA in the prediction of PE. In this study, serum levels of total SA showed a significant correlation with diastolic blood pressure, proteinuria and serum levels of uric acid.
The studies that have been conducted for the last years demonstrated that SA contained about 10 humanspecific genetic variations (26) . Again, this studies demonstrated the correlation between human autoimmune diseases and genetic variants of the sialic acid acetylesterase enzyme (SIAE), which consisted the most commonly seen modification of SAs present on the cell surface of the mammalians (27) . In our study, SIAE gene variations were evaluated in the PE, which was human-specific pathology and for which autoimmune mechanisms were thought to play a role in the physiopathology, the rate of gene variation was found to be significantly higher in the preeclamptic patients compared to control group, and the likelihood of gene variation in the preeclamptic pregnant women was found to be 10.4 fold higher compared to controls.
This result was consistent with those of the study performed by Tsai et al. (28) . Tsai et al. detected a dysregulation of SIAE gene transcription in the placenta of the preeclamptic pregnant women. Again, Winn VD et al. (29) showed the correlation between Sialic Acid-Binding Immunoglobulin-LikeLectin-6 gene expression and severe PE and stated that serum levels of these proteins could be used for the diagnosis or the prediction of PE. Our study has been the first study in the literature to evaluate the role of serum levels of total SA in the prediction of PE and to concomitantly demonstrate that SIAE gene variation was a risk factor for PE.
Consequently, in this study, it was determined that, in preeclamptic pregnant women, increased serum levels of total SA and SIAE gene variation increased the risk for PE occurrence by 10.4 fold. New prospective studies with large series of patients are warranted to reveal the importance of serum levels of total SA in the prediction of PE in the early gestational weeks and to evaluate whether the patients with the potential of preeclampsia development could be determined by performing a genetic analysis in the preconceptional period.
